000 | 00971 a2200301 4500 | ||
---|---|---|---|
005 | 20250517183759.0 | ||
264 | 0 | _c20171113 | |
008 | 201711s 0 0 eng d | ||
022 | _a1538-3598 | ||
024 | 7 |
_a10.1001/jama.2017.14295 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAxelsson, Kristian F | |
245 | 0 | 0 |
_aAlendronate and Hip Fracture in Patients Using Glucocorticoids-Reply. _h[electronic resource] |
260 |
_bJAMA _c11 2017 |
||
300 |
_a1712 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAlendronate |
650 | 0 | 4 | _aBone Density |
650 | 0 | 4 | _aBone Density Conservation Agents |
650 | 0 | 4 | _aGlucocorticoids |
650 | 0 | 4 | _aHip Fractures |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aOsteoporosis, Postmenopausal |
700 | 1 | _aNilsson, Anna G | |
700 | 1 | _aLorentzon, Mattias | |
773 | 0 |
_tJAMA _gvol. 318 _gno. 17 _gp. 1712 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jama.2017.14295 _zAvailable from publisher's website |
999 |
_c27765705 _d27765705 |